Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Normal Diffusion-Weighted MRI During the Acute Stage of Central Pontine Myelinolysis.
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
Disease Activity during the First Year Predicts Clinical Long-Term Outcomes in Patients with Multiple Sclerosis: Fingolimod Treatment Benefit
Development of Ms Budget Manager: A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms).
Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Vascular malformation mimicking multiple sclerosis active plaque: Usefulness of susceptibility weighted imaging (SWI) to perform correct diagnosis.
A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
Identifying clues to molecular etiology of multiple sclerosis in South Indian patients.
Electroactive biodegradable polyurethane significantly enhanced Schwann cells myelin gene expression and neurotrophin secretion for peripheral nerve tissue engineering.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Evoked potentials are useful for diagnosis of neuromyelitis optica spectrum disorder.
Health-related quality of life in multiple sclerosis: role of cognitive appraisals of self, illness and treatment.
[Encephalopathy and neuromyelitis optica: the importance of recognising atypical symptoms].
Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
Comparison of energy consumption in different clinical forms multiple sclerosis with normal subjects (cohort study).
Progression, Symptoms and Psychosocial Concerns among Those Severely Affected by Multiple Sclerosis: A Mixed-Methods Cross-Sectional Study of Black Caribbean and White British People.
Application of the 2012 revised diagnostic definitions for paediatric multiple sclerosis and immune-mediated central nervous system demyelination disorders.
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
Differential effects of myelin basic protein-activated Th1 and Th2 cells on the local immune microenvironment of injured spinal cord.
Fingolimod and cardiac risk: latest findings and clinical implications.
Pages
« first
‹ previous
…
714
715
716
717
718
719
720
721
722
…
next ›
last »